Development of antibody-inducing vaccine models by analysis of B404 which neutralizes various SIV strains
Project/Area Number |
26430091
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Laboratory animal science
|
Research Institution | Kumamoto University |
Principal Investigator |
Kuwata Takeo 熊本大学, エイズ学研究センター, 助教 (70346063)
|
Co-Investigator(Renkei-kenkyūsha) |
MATSUSHITA Shuzo 熊本大学, エイズ学研究センター, 教授 (00199788)
IGARASHI Tatsuhiko 京都大学, ウイルス研究所, 教授 (90467431)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | antibody / SIV / vaccine / HIV / 中和抗体 / アカゲザル / ワクチン |
Outline of Final Research Achievements |
SIV-infected macaques, which is an animal model of HIV infection, was used for analysis to develop antibody-inducing vaccines. Binding of potent anti-SIV neutralizing antibody B404 was not affected by point mutations on Env, and was suggested to require the structure of antigen-binding domain with negative charges. The biased induction of B404-class antibodies in macaques suggested the effect of host factors in antibody induction. Moreover, maturation of antibodies resulted in increase of neutralization activity against homologous virus, but did not associated with cross-neutralization activity against heterologous viruses
|
Report
(4 results)
Research Products
(22 results)
-
[Journal Article] Enhanced antibody-mediated neutralization of HIV-1 variants that are resistant to fusion inhibitors2016
Author(s)
Alam, M., Kuwata, T., Shimura, K., Yokoyama, M., Ramirez Valdez, K. P., Tanaka, K., Maruta, Y., Oishi, S., Fujii, N., Sato, H., Matsuoka M. and Matsushita S.
-
Journal Title
Retrovirology
Volume: 13
Issue: 1
Pages: 70-70
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Cross-Neutralization Activity of Single-Chain Variable Fragment (scFv) Derived from Anti-V3 Monoclonal Antibodies Mediated by Post-Attachment Binding2016
Author(s)
Maruta, Y., Kuwata, T., Tanaka, K., Alam, M., Valdez, K. P., Egami, Y., Yoshiaki Suwa, Y., Morioka, H. and Matsushita, S.
-
Journal Title
Japanese Journal of Infectious Diseases
Volume: 69
Issue: 5
Pages: 395-404
DOI
NAID
ISSN
1344-6304, 1884-2836
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains.2015
Author(s)
Ramirez, K.P., Kuwata, T., Maruta, Y, Tanaka K., Muntasir, A., Yoshimura, K., Matsushita, S.
-
Journal Title
Virology
Volume: 475
Pages: 187-203
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Mutations in gp41 is Critical to Escape from B404, a Broad Neutralizing Antibody Against SIV, Which Recognizes a V3/V4 Conformational Epitope2014
Author(s)
Takeo Kuwata, Kazuhisa Yoshimura, Fan Wu, Ilnour Ourmanov, Vanessa M. Hirsch, Masaru Yokoyama, Hironori Sato and Shuzo Matsushita
Organizer
32nd Annual Symposium on Nonhuman Primate Models for AIDS
Place of Presentation
The Nines Hotel (Portland, Oregon, USA)
Year and Date
2014-11-11 – 2014-11-14
Related Report
-
-
-